Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Nanomedicine. 2012;7:2281-92. doi: 10.2147/IJN.S27540. Epub 2012 May 10.

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity.

Author information

  • 1Department of Mechanical and Aerospace Engineering, UCLA, Los Angeles, CA, USA.

Abstract

BACKGROUND:

Infectious diseases cause many molecular assemblies and pathways within cellular signaling networks to function aberrantly. The most effective way to treat complex, diseased cellular networks is to apply multiple drugs that attack the problem from many fronts. However, determining the optimal combination of several drugs at specific dosages to reach an endpoint objective is a daunting task.

METHODS:

In this study, we applied an experimental feedback system control (FSC) method and rapidly identified optimal drug combinations that inhibit herpes simplex virus-1 infection, by only testing less than 0.1% of the total possible drug combinations.

RESULTS:

Using antiviral efficacy as the criterion, FSC quickly identified a highly efficacious drug cocktail. This cocktail contained high dose ribavirin. Ribavirin, while being an effective antiviral drug, often induces toxic side effects that are not desirable in a therapeutic drug combination. To screen for less toxic drug combinations, we applied a second FSC search in cascade and used both high antiviral efficacy and low toxicity as criteria. Surprisingly, the new drug combination eliminated the need for ribavirin, but still blocked viral infection in nearly 100% of cases.

CONCLUSION:

This cascade search provides a versatile platform for rapid discovery of new drug combinations that satisfy multiple criteria.

KEYWORDS:

FSC; HSV-1; combinatorial drug optimization; drug combination; drug screening; feedback system control

PMID:
22654513
[PubMed - indexed for MEDLINE]
PMCID:
PMC3363951
Free PMC Article

Images from this publication.See all images (6)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Write to the Help Desk